Advertisement

Topics

Sirion GmbH Company Profile

13:01 EDT 19th March 2019 | BioPortfolio

SIRION offers tools and services for RNAi expression and solutions for customized adenovirus-mediated gene delivery. SIRIONs proprietary Q-tech technology enables efficient RNAi driven gene silencing without siRNA transfection.

Location

Germany


News Articles [187 Associated News Articles listed on BioPortfolio]

Orchard Therapeutics and SIRION Biotech Announce Licensing Agreement

Orchard Therapeutics (NASDAQ:ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through innovat...

Denali, SIRION collaborate on AAV gene therapies for neurodegenerative diseases

SIRION Biotech GMBH and Denali Therapeutics Inc. have agreed to jointly develop adeno-associated virus (AAV) vectors to create CNS gene therapies capable of crossing the blood-brain barrier (BBB). AAV...

SIRION Biotech Expands US Presence in Massachusetts

Europe’s Leading Commercial Provider of Viral Vector Technology Opens Local Office in Cambridge SIRION Biotech International Inc., a wholly-owned subsidiary of SIRION...

Orchard & SIRION Enter License Agreement

SIRION to provide Orchard with a license to its proprietary lentiviral transduction enhancer LentiBOOST™

Germany's Sirion Biotech Opens U.S. HQ in Cambridge

Sirion Biotech International threw a Bavarian-themed grand opening party at the Forsythe Institute on Feb. 1. The new headquarters are in Cambridge, Mass and currently have five employees.

Germany's Sirion Biotech Launches New U.S. Headquarters in Cambridge

Sirion Biotech International threw a Bavarian-themed grand opening party at the Forsythe Institute on Feb. 1. The new headquarters are in Cambridge, Mass and currently have five employees.

SIRION Biotech Names LaVoieHealthScience as Strategic Communications Agency of Record

SIRION Biotech Plans Path for U.S. Market Expansion LaVoieHealthScience (LHS), an integrated investor and public relations agency focused on advancing health and scienc...

Deal Watch: Denali Partners With Sirion To Take On The Blood-Brain Barrier

Denali will collaborate with Sirion in Parkinson’s and Alzheimer’s diseases. Meanwhile, Lundbeck and Elevian unveil drug development partnerships with technology...  

Drugs and Medications [15 Associated Drugs and Medications listed on BioPortfolio]

La prairie switzerland [juvena produits de beaute gmbh]

Package.Label Principle Display Panel

Tobramycin [holopack verpackungstechnik gmbh]

Tobramycin Inhalation Solution (300 mg/5 mL)

Lonhala [holopack verpackungstechnik gmbh]

Glycopyrrolate Inhalation Solution (25 µg/mL)

Etoposide [thymoorgan gmbh pharmazir & co. k.g]

Etoposide Injection, USP

Oxygen [metro aire ltd]

Oxygen

PubMed Articles [12 Associated PubMed Articles listed on BioPortfolio]

A comparison of different farrowing systems - Part 1: Effects on the activity of the sow.

The aim of this study was to determine whether a 3-axis accelerometer (MSR 145B V5.106, MSR Electronics GmbH, Seuzach, Switzerland) can continuously record and display the activity behaviour of sows o...

Field study on loose farrowing in cold barns.

The aim of this field study was to examine the loose farrowing system in view of practicability, particularly to monitor piglet losses and their causes, on a farm proceeding in accordance with the BIO...

Evaluation of the real-world impact of rotational thromboelastometry-guided transfusion protocol in patients undergoing proximal aortic surgery.

Complex aortic procedures are potentially associated with important blood loss and coagulopathy. The aim of this study was to assess the impact of rotational thromboelastometry (ROTEM, Tem Internation...

Evaluation of Physicochemical Properties of New Calcium Silicate-Based Sealer.

This study aimed to evaluate the physicochemical properties of a calcium silicate-based sealer (Sealer Plus BC; MK Life, Porto Alegre, Brazil) compared with an epoxy-resin sealer (AH Plus; Dentsply De...

Sequential Solution Polymerization of Poly(3,4-ethylenedioxythiophene) Using VO as Oxidant for Flexible Touch Sensors.

Various in situ synthesis methods have been developed for the polymerization of 3,4-ethylenedioxythiophene monomers, such as electropolymerization, oxidative chemical vapor deposition, and vapor phase...

Clinical Trials [52 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015

The user performance evaluation shows whether people with diabetes are able to obtain accurate measurement results with a blood glucose monitoring system. In this study, user performance e...

Telemedical Examination of a Three-Component Oculomotor Testing Battery

The study investigates the feasibility and safety of the telemedical implementation of three diagnostic oculomotor tests using a video-oculography device and an extended teleconferencing s...

Companies [541 Associated Companies listed on BioPortfolio]

SIRION Biotech International Inc.

SIRION Biotech International is a wholly-owned subsidiary of SIRION Biotech GmbH providing custom engineering and manufacturing services of viral vectors for the life sciences ind...

Sirion GmbH

SIRION offers tools and services for RNAi expression and solutions for customized adenovirus-mediated gene delivery. SIRIONs proprietary Q-tech technology enables efficient RNAi driven gene silencing ...

SIRION Biotech GmbH

Founded in 2005, SIRION Biotech is a global leader in developing research and commercial grade viral vector solutions for industry and academic partners who are developing gene th...

SIRION

Nil

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

More Information about "Sirion GmbH" on BioPortfolio

We have published hundreds of Sirion GmbH news stories on BioPortfolio along with dozens of Sirion GmbH Clinical Trials and PubMed Articles about Sirion GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sirion GmbH Companies in our database. You can also find out about relevant Sirion GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...


Corporate Database Quicklinks



Searches Linking to this Company Record